PROLX PHARMACEUTICALS CORP.
ProlX Pharmaceuticals Corp. is a privately held bio-pharmaceutical company develops therapeutics for the treatment of cancer.
PROLX PHARMACEUTICALS CORP.
Industry:
Biotechnology Pharmaceutical
Founded:
1996-01-01
Address:
Tucson, Arizona, United States
Country:
United States
Status:
Active
Similar Organizations
Altum Pharmaceuticals
Altum Pharmaceuticals operates as a biopharmaceutical company.
CPEX Pharmaceuticals
CPEX Pharmaceuticals is a pharmaceutical company.
Erimos Pharmaceuticals
Erimos Pharmaceuticals is a biopharmaceutical company
Olio Pharmaceuticals
Olio Pharmaceuticals (Olio) is a Bio-pharmaceutical company.
SLIL Biomedical
SLIL Biomedical Corp. is a biopharmaceutical company.
More informations about "ProlX Pharmaceuticals Corp." on Search Engine
Biomira Inc. Announces Acquisition Of ProlX Pharmaceuticals …
Oct 31, 2006 ProlX Pharmaceuticals Corporation is a private biotechnology company located in Tucson, AZ and Houston, TX, dedicated to the discovery of novel therapies for …See details»
ProlX Pharmaceuticals Company Profile | Management and
ProlX Pharmaceuticals Corporation is a private biotechnology company located in Tucson, AZ and Houston, TX, dedicated to the discovery of novel therapies for the treatment of …See details»
ProlX Pharmaceuticals Corp - Company Profile and News
Company profile page for ProlX Pharmaceuticals Corp including stock price, company news, executives, board members, and contact information.See details»
| BioWorld
Nov 1, 2011 Just two months after appointing a new leadership team, Biomira Inc. expanded its oncology pipeline by acquiring Tucson, Ariz.-based ProlX Pharmaceuticals …See details»
Biomira Announces Acquisition of ProlX Pharmaceuticals
Biomira Inc. announced that it has acquired ProlX Pharmaceuticals Corporation, of Tucson, Arizona, and Houston, Texas, a privately-held biopharmaceutical company …See details»
ProlX Pharmaceuticals - Overview, News & Similar companies
ProlX Pharmaceuticals Corporation is a private biotechnology company located in Tucson, AZ and Houston, TX, dedicated to the discovery of novel the rapies for the …See details»
PROLX PHARMACEUTICALS CORPORATION | SBIR.gov
ProlX Pharmaceuticals has demonstrated that there is strong evidence for the following: 1) PtdIns-3-kinase and Akt are two novel validated molecular targets for anti-cancer drug …See details»
Drug evaluation: the thioredoxin inhibitor PX-12 in the treatment of ...
Biomira Inc, following its acquisition of ProlX Pharmaceutical Corp, is developing PX-12, an inhibitor of thioredoxin, for the potential treatment of cancer. PX-12 has completed phase …See details»
SURVIVAL SIGNALING INHIBITORS AS CANCER DRUGS
ProlX Pharmaceuticals has demonstrated that there is strong evidence for the following: 1) PtdIns-3-kinase and Akt are two novel validated molecular targets for anti-cancer drug …See details»
ProlX Pharmaceuticals Corp. - Updates, News, Events
Oct 1, 2006 Recent News & Activity. Acquisition • Oct 1, 2006. Cascadian Therapeutics acquired ProlX Pharmaceuticals Corp. for an undisclosed amount. Discover more …See details»
A Hypoxia Activated HIF-1 &Inhibitor for Cancer Therapy
Aug 1, 2003 ProlX Pharmaceuticals, a company focusing on redox targets for development of anti-cancer therapies, has identified PX-478 as a novel hypoxia inducible factor (HIF) …See details»
ProlX Pharmaceuticals Corp. acquired by Cascadian …
Cascadian Therapeutics acquires ProlX Pharmaceuticals Corp. on 2006-10-01 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial - SBIR
This proposal seeks to undertake further clinical development of a novel targeted agent, PX-12. ProIX Pharmaceuticals has demonstrated there is strong evidence for the following: …See details»
Biomira Acquires ProIX Pharmaceuticals. - Free Online Library
Oct 31, 2006 Biomira Inc. today announced the acquisition of ProlX Pharmaceuticals Corporation of Tucson, Ariz., and Houston, Texas, a privately held biopharmaceutical …See details»
UNIQUE THIOREDOXIN INHIBITORS AS ANTI-CANCER …
DESCRIPTION: ProlX Pharmaceutical has demonstrated that thioredoxin has an important role in maintaining the transformed phenotype of some human cancers as well …See details»
AGREEMENT AND PLAN OF REORGANIZATION BY AND …
THIS AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is made and entered into as of October 30, 2006 by and among Biomira Inc. a Canadian corporation …See details»
ProlX Pharmaceuticals Corp. - Crunchbase
ProlX Pharmaceuticals Corp. is a biopharmaceutical company.See details»
ProlX Pharmaceuticals Corporation | LinkedIn
About us. Industry. Biotechnology Research. Company size. 2-10 employees. Headquarters. Tucson, AZ. Locations. 221 E 6th St. Tucson, AZ 85705, US. Get …See details»
PROLX PHARMACEUTICALS CORPORATION in Bothell, WA
Jun 1, 2024 Discover Company Info on PROLX PHARMACEUTICALS CORPORATION in Bothell, WA, such as Contacts, Addresses, Reviews, and Registered Agent.See details»
PI-3 kinase inhibitor PX-866 as anticancer therapy | SBIR.gov
The objectives of this Phase I study to be conducted by ProIX Pharmaceuticals are to gain an understanding of the biological activity of the lead agent, PX-866.See details»